{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:09:56Z","timestamp":1793747396094,"version":"4.6.1"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119559","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:09:07Z","timestamp":1779998947000},"page":"119559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mitochondrial metabolic reprogramming in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"200","author":[{"given":"Yuting","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119559_bib1","article-title":"11th edition of the IDF diabetes atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","author":"Genitsaridi","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119559_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119559_bib3","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00006.2014","article-title":"Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart","volume":"307","author":"Pham","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2026.119559_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155313","article-title":"Mitochondrial quality control mechanisms as molecular targets in diabetic heart","volume":"137","author":"Chang","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2026.119559_bib5","series-title":"Biochemistry and Molecular Biology","author":"Zhou","year":"2020"},{"key":"10.1016\/j.biopha.2026.119559_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119559_bib7","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2026.119559_bib8","first-page":"83","article-title":"Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum","volume":"3","author":"Wanders","year":"2015","journal-title":"Front. Cell. Dev. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119559_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","article-title":"The multifaceted contributions of mitochondria to cellular metabolism","volume":"20","author":"Spinelli","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibs.2011.09.003","article-title":"The complexity of cardiolipin in health and disease","volume":"37","author":"Claypool","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2026.119559_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2014.04.001","article-title":"Metabolism and function of mitochondrial cardiolipin","volume":"55","author":"Ren","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.119559_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1083\/jcb.201602007","article-title":"MICOS and phospholipid transfer by ups2-mdm35 organize membrane lipid synthesis in mitochondria","volume":"213","author":"Aaltonen","year":"2016","journal-title":"J. Cell. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbalip.2016.08.006","article-title":"Intramitochondrial phospholipid trafficking","volume":"1862","author":"Tatsuta","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.biopha.2026.119559_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119559_bib15","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","article-title":"Broad activation of the ubiquitin-proteasome system by parkin is critical for mitophagy","volume":"20","author":"Chan","year":"2011","journal-title":"Hum. Mol. Genet"},{"issue":"7","key":"10.1016\/j.biopha.2026.119559_bib16","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033936","article-title":"Mitochondrial proteolysis and metabolic control","volume":"11","author":"Ahola","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119559_bib17","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/S0021-9258(18)68969-0","article-title":"Role of mitochondrial transamination in branched chain amino acid metabolism","volume":"263","author":"Hutson","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119559_bib18","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7150\/ijbs.11827","article-title":"Induction of phosphoenolpyruvate carboxykinase (PEPCK) during acute acidosis and its role in acid secretion by v-ATPase-expressing ionocytes","volume":"11","author":"Furukawa","year":"2015","journal-title":"Int. J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2026.119559_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137037","article-title":"Origin and roles of alanine and glutamine in gluconeogenesis in the liver, kidneys, and small intestine under physiological and pathological conditions","volume":"25","author":"Hole\u010dek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102838","article-title":"Regulation and function of the mammalian tricarboxylic acid cycle","volume":"299","author":"Arnold","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib21","doi-asserted-by":"crossref","first-page":"H118","DOI":"10.1152\/ajpheart.00932.2010","article-title":"Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways","volume":"300","author":"Anderson","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2026.119559_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117148","article-title":"High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes","volume":"241","author":"Rizwan","year":"2020","journal-title":"Life Sci."},{"issue":"21","key":"10.1016\/j.biopha.2026.119559_bib23","doi-asserted-by":"crossref","first-page":"8182","DOI":"10.1074\/jbc.RA118.002066","article-title":"Restoring mitochondrial calcium uniporter expression in diabetic mouse heart improves mitochondrial calcium handling and cardiac function","volume":"293","author":"Suarez","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119559_bib24","article-title":"Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the warburg effect, ketones, and SGLT2 inhibitors","author":"Carrera-Bastos","year":"2025","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2026.119559_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003075","article-title":"Mitochondrial energy metabolism in diabetic cardiomyopathy: physiological adaption, pathogenesis, and therapeutic targets","volume":"137","author":"Ye","year":"2024","journal-title":"Chin. Med. J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119559_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/cvr\/cvx018","article-title":"Metabolic remodeling in diabetic cardiomyopathy","volume":"113","author":"Chong","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.14336\/AD.2020.1217","article-title":"CD36 signaling in diabetic cardiomyopathy","volume":"12","author":"Zhang","year":"2021","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvr212","article-title":"Lipotoxicity in type 2 diabetic cardiomyopathy","volume":"92","author":"van de Weijer","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr. Heart Fail. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2026.119559_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113259","article-title":"The contribution of cardiac fatty acid oxidation to diabetic cardiomyopathy severity","volume":"10","author":"Karwi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119559_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1375400","article-title":"Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy","volume":"11","author":"Zeng","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib33","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","article-title":"The randle cycle revisited: a new head for an old hat","volume":"297","author":"Hue","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"47","key":"10.1016\/j.biopha.2026.119559_bib34","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036299","article-title":"The essential role of glutamine metabolism in diabetic cardiomyopathy: a review","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.biopha.2026.119559_bib35","doi-asserted-by":"crossref","first-page":"706","DOI":"10.34133\/research.0706","article-title":"Defective endothelial glutaminolysis contributes to impaired angiogenesis and poor ischemic tissue repair in diabetes","volume":"8","author":"Zhao","year":"2025","journal-title":"Research"},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030460","article-title":"Kynurenine pathway in diabetes mellitus-novel pharmacological target?","volume":"12","author":"Kozie\u0142","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119559_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1406856","article-title":"The role of the kynurenine pathway in cardiovascular disease","volume":"11","author":"Yang","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib38","article-title":"Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis","volume":"19","author":"Wu","year":"2024","journal-title":"Open Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.119559_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/biom15070916","article-title":"Emerging insights into the relationship between amino acid metabolism and diabetic cardiomyopathy","volume":"15","author":"Wen","year":"2025","journal-title":"Biomolecules"},{"issue":"29","key":"10.1016\/j.biopha.2026.119559_bib40","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha","volume":"104","author":"J\u00e4ger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00395-013-0329-1","article-title":"Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1\u03b1 signaling contributing to increased vulnerability in diabetic heart","volume":"108","author":"Yan","year":"2013","journal-title":"Basic. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119559_bib42","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3892\/mmr.2020.11599","article-title":"Metformin protects high glucose\u2011cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway","volume":"22","author":"Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib43","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41467-017-00520-9","article-title":"Ampk phosphorylation of ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy","volume":"8","author":"Laker","year":"2017","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.biopha.2026.119559_bib44","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1016\/j.molcel.2024.10.025","article-title":"Opposing roles for AMPK in regulating distinct mitophagy pathways","volume":"84","author":"Longo","year":"2024","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.biopha.2026.119559_bib45","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1074\/jbc.M113.521062","article-title":"Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: Potential role of attenuated oxidative stress and altered contractile protein expression","volume":"289","author":"Das","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119559_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.750382","article-title":"Mitophagy in diabetic cardiomyopathy: roles and mechanisms","volume":"9","author":"Zheng","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MOL.0b013e328352dd03","article-title":"Connecting mTORC1 signaling to SREBP-1 activation","volume":"23","author":"Bakan","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119559_bib48","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type m2 is critical for aerobic glycolysis and tumor growth","volume":"108","author":"Sun","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113417","article-title":"Silencing RIPK1\/mTORC1 signalling attenuated the inflammation and oxidative stress in diabetic cardiomyopathy","volume":"422","author":"Liu","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/db14-0874","article-title":"Mitochondrial hormesis and diabetic complications","volume":"64","author":"Sharma","year":"2015","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.biopha.2026.119559_bib51","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304","author":"Mori","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2026.119559_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6823-14-11","article-title":"Partial deficiency of HIF-1\u03b1 stimulates pathological cardiac changes in streptozotocin-induced diabetic mice","volume":"14","author":"Bohuslavova","year":"2014","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.biopha.2026.119559_bib53","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.3390\/ijms24108604","article-title":"The role of cardiac fibrosis in diabetic cardiomyopathy: from pathophysiology to clinical diagnostic tools","author":"Pan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119559_bib54","article-title":"PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119559_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13579","article-title":"TGF-\u03b23 mediates mitochondrial dynamics through the p-smad3\/AMPK pathway","volume":"57","author":"Du","year":"2024","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib56","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41467-017-00664-8","article-title":"Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated erk5 signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119559_bib57","article-title":"Mir-340-5p mediates cardiomyocyte oxidative stress in diabetes-induced cardiac dysfunction by targeting mcl-1","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","article-title":"Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation","volume":"7","author":"Mori","year":"2014","journal-title":"Circulation Heart Failure"},{"key":"10.1016\/j.biopha.2026.119559_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154910","article-title":"Heart failure in diabetes","volume":"125","author":"Jankauskas","year":"2021","journal-title":"Metabolism"},{"issue":"23","key":"10.1016\/j.biopha.2026.119559_bib60","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.21037\/atm-20-2205","article-title":"Subcellular microRNAs in diabetic cardiomyopathy","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Medicine2020"},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/dmrr.1054","article-title":"Mir133a regulates cardiomyocyte hypertrophy in diabetes","volume":"26","author":"Feng","year":"2010","journal-title":"Diabetes-Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2026.119559_bib62","first-page":"683","article-title":"Induction of autophagy markers is associated with attenuation of mir-133a in diabetic heart failure patients undergoing mechanical unloading","volume":"7","author":"Nandi","year":"2015","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/jcmm.12218","article-title":"Cardiac mir-133a overexpression prevents early cardiac fibrosis in diabetes","volume":"18","author":"Chen","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"20","key":"10.1016\/j.biopha.2026.119559_bib65","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21\u2013sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biopha.2026.119559_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018913","article-title":"Sirtuin 3 alleviates diabetic cardiomyopathy by regulating TIGAR and cardiomyocyte metabolism","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2026.119559_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.679655","article-title":"Histone deacetylases in the pathogenesis of diabetic cardiomyopathy","volume":"12","author":"Ke","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2026.119559_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117010","article-title":"Histone deacetylases and inhibitors in diabetes mellitus and its complications","volume":"177","author":"Wang","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2026.119559_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004507","article-title":"Hypermethylation of hepatic mitochondrial ND6 provokes systemic insulin resistance","volume":"8","author":"Cao","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2026.119559_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/bjbs.2025.15375","article-title":"Mitochondrial DNA mutations and epigenetic regulation in type 2 diabetes mellitus development","volume":"82","author":"Koh","year":"2025","journal-title":"Br. J. Biomed. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119559_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123065","article-title":"Diabetic hearts exhibit global DNA hypermethylation that alter the mitochondrial functional genes to enhance the sensitivity of the heart to ischemia reperfusion injury","volume":"10","author":"Boovarahan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119559_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1204483","article-title":"Mitochondrial epigenetics in aging and cardiovascular diseases","volume":"10","author":"Mongelli","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"17","key":"10.1016\/j.biopha.2026.119559_bib73","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/ars.2015.6293","article-title":"Mitochondrial dynamics in diabetic cardiomyopathy","volume":"22","author":"Galloway","year":"2015","journal-title":"Antioxid. Redox Signal"},{"issue":"733","key":"10.1016\/j.biopha.2026.119559_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade8647","article-title":"DRAK2 suppresses autophagy by phosphorylating ULK1 at ser(56) to diminish pancreatic \u03b2 cell function upon overnutrition","volume":"16","author":"Lu","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.biopha.2026.119559_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cells7120235","article-title":"SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM","volume":"7","author":"Bagul","year":"2018","journal-title":"Cells"},{"issue":"10254","key":"10.1016\/j.biopha.2026.119559_bib76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"7609","key":"10.1016\/j.biopha.2026.119559_bib77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nature18302","article-title":"Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation","volume":"534","author":"M\u00fcnch","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12997\/jla.2022.11.1.1","article-title":"SGLT2 inhibitors and ketone metabolism in heart failure","volume":"11","author":"Saucedo-Orozco","year":"2022","journal-title":"J. Lipid Atheroscler."},{"key":"10.1016\/j.biopha.2026.119559_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2026.119559_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109252","article-title":"GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1\u03b2-induced metabolic disturbance and mitochondrial dysfunction","volume":"332","author":"Zhang","year":"2020","journal-title":"Chem. Biol. Inter."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-024-05558-9","article-title":"The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy","volume":"82","author":"Kuo","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"10","key":"10.1016\/j.biopha.2026.119559_bib82","first-page":"1358","article-title":"Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via sirt1\/AMPK signaling","volume":"24","author":"Zhang","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119559_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119559_bib84","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/461967","article-title":"Alteration of energy substrates and ROS production in diabetic cardiomyopathy","volume":"2013","author":"Lorenzo","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"17","key":"10.1016\/j.biopha.2026.119559_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176043","article-title":"Mitochondrial dysfunction in diabetic cardiomyopathy: the possible therapeutic roles of phenolic acids","volume":"21","author":"Jubaidi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","article-title":"Therapeutic targeting of mitochondrial superoxide in hypertension","volume":"107","author":"Dikalova","year":"2010","journal-title":"Circ. Res."},{"issue":"15","key":"10.1016\/j.biopha.2026.119559_bib87","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","article-title":"Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications","volume":"117","author":"Zielonka","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2026.119559_bib88","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","article-title":"Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy","volume":"90","author":"Ni","year":"2016","journal-title":"Free. Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26030944","article-title":"Elamipretide: a review of its structure, mechanism of action, and therapeutic potential","volume":"26","author":"Tung","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"26","key":"10.1016\/j.biopha.2026.119559_bib90","doi-asserted-by":"crossref","first-page":"15363","DOI":"10.1073\/pnas.2002250117","article-title":"Mitochondrial protein interaction landscape of SS-31","volume":"117","author":"Chavez","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib91","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s42003-020-1101-3","article-title":"The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats","volume":"3","author":"Allen","year":"2020","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib92","first-page":"147","article-title":"Elamipretide improves mitochondrial function in the failing human heart","volume":"4","author":"Chatfield","year":"2019","journal-title":"JACC-Basic Transl. Sci."},{"issue":"7285","key":"10.1016\/j.biopha.2026.119559_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature08778","article-title":"SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation","volume":"464","author":"Hirschey","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib94","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7150\/ijbs.102834","article-title":"Mitochondrial SIRT2-mediated CPT2 deacetylation prevents diabetic cardiomyopathy by impeding cardiac fatty acid oxidation","volume":"21","author":"Guo","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"25","key":"10.1016\/j.biopha.2026.119559_bib95","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.123.066039","article-title":"Raising NAD(+) level stimulates short-chain dehydrogenase\/reductase proteins to alleviate heart failure independent of mitochondrial protein deacetylation","volume":"148","author":"Walker","year":"2023","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.biopha.2026.119559_bib96","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.7150\/ijbs.75402","article-title":"Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"18","author":"Cai","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119559_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2016.23","article-title":"Mitonuclear communication in homeostasis and stress","volume":"17","author":"Quir\u00f3s","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119559_bib98","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ejcts\/ezz326","article-title":"Mitochondrial transplantation for myocardial protection in diabetic hearts","volume":"57","author":"Doulamis","year":"2020","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib99","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/acsnano.2c05286","article-title":"Intravenous transplantation of an ischemic-specific peptide-TPP-mitochondrial compound alleviates myocardial ischemic reperfusion injury","volume":"17","author":"Sun","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12967-023-04203-6","article-title":"Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases","volume":"21","author":"Sun","year":"2023","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119559_bib101","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ymthe.2023.02.016","article-title":"Delivery of mitochondria confers cardioprotection through mitochondria replenishment and metabolic compliance","volume":"31","author":"Zhang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.119559_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132227","article-title":"Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease","volume":"410","author":"Baharvand","year":"2024","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib103","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41587-023-01791-y","article-title":"Strand-selective base editing of human mitochondrial DNA using mitoBEs","volume":"42","author":"Yi","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib104","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","article-title":"Mitochondrial genome engineering: the revolution may not be CRISPR-ized","volume":"34","author":"Gammage","year":"2018","journal-title":"Trends Genet"},{"key":"10.1016\/j.biopha.2026.119559_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.883459","article-title":"Current progress of mitochondrial genome editing by CRISPR","volume":"13","author":"Yin","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2026.119559_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.627050","article-title":"Adapting CRISPR\/cas9 system for targeting mitochondrial genome","volume":"12","author":"Hussain","year":"2021","journal-title":"Front. Genet"},{"issue":"1","key":"10.1016\/j.biopha.2026.119559_bib107","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21794-0","article-title":"Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import","volume":"12","author":"Schmiderer","year":"2022","journal-title":"Sci. Rep."},{"issue":"7817","key":"10.1016\/j.biopha.2026.119559_bib108","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib109","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211011016","article-title":"Safety of four SGLT2 inhibitors in three chronic diseases: a meta-analysis of large randomized trials of SGLT2 inhibitors","volume":"18","author":"Qiu","year":"2021","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"12","key":"10.1016\/j.biopha.2026.119559_bib110","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","article-title":"SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits","volume":"65","author":"Marilly","year":"2022","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.biopha.2026.119559_bib111","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1212\/WNL.0000000000207402","article-title":"Efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy: the MMPOWER-3 randomized clinical trial","volume":"101","author":"Karaa","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.biopha.2026.119559_bib112","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.diabres.2015.09.014","article-title":"MTOR inhibitors and diabetes","volume":"110","author":"Verg\u00e8s","year":"2015","journal-title":"Diabetes Res. Clin. Pr."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T22:48:32Z","timestamp":1787438912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":112,"alternative-id":["S0753332226005950"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119559","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial metabolic reprogramming in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119559"}}